• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals.肽核酸依赖性假像可能导致假阳性三链体基因编辑信号。
Proc Natl Acad Sci U S A. 2021 Nov 9;118(45). doi: 10.1073/pnas.2109175118.
2
Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing.肽核酸作为一种用于定点基因编辑的工具。
Molecules. 2018 Mar 11;23(3):632. doi: 10.3390/molecules23030632.
3
Poly(Lactic-co-Glycolic Acid) Nanoparticle Delivery of Peptide Nucleic Acids In Vivo.体内肽核酸的聚(乳酸-共-乙醇酸)纳米粒子传递。
Methods Mol Biol. 2020;2105:261-281. doi: 10.1007/978-1-0716-0243-0_17.
4
Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors.纳米颗粒递送三链体形成的 PNAs,用于 CD34+ 人类造血祖细胞中的特异性基因组重组。
Mol Ther. 2011 Jan;19(1):172-80. doi: 10.1038/mt.2010.200. Epub 2010 Sep 21.
5
Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition.通过沃森-克里克识别进行体内位点特异性基因组编辑的单链γ肽核酸。
Curr Gene Ther. 2014;14(5):331-42. doi: 10.2174/1566523214666140825154158.
6
Peptide Nucleic Acids and Gene Editing: Perspectives on Structure and Repair.肽核酸与基因编辑:结构与修复视角。
Molecules. 2020 Feb 8;25(3):735. doi: 10.3390/molecules25030735.
7
Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.纳米粒介导三聚体形成 PNA 和供体 DNA 的系统传递可介导体内人造血细胞的特异性基因组编辑。
Gene Ther. 2013 Jun;20(6):658-69. doi: 10.1038/gt.2012.82. Epub 2012 Oct 18.
8
Triplex-forming peptide nucleic acids induce heritable elevations in gamma-globin expression in hematopoietic progenitor cells.三聚体形成肽核酸诱导造血祖细胞中γ-珠蛋白表达的可遗传性升高。
Mol Ther. 2013 Mar;21(3):580-7. doi: 10.1038/mt.2012.262. Epub 2013 Jan 22.
9
Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.利用包裹在 PLGA 纳米粒中的短反种子 PNAs 进行下一代 miRNA 抑制。
J Control Release. 2020 Nov 10;327:406-419. doi: 10.1016/j.jconrel.2020.08.026. Epub 2020 Aug 21.
10
Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.靶向基因组编辑恢复人源化 X-SCID 多能干细胞疾病模型中的 T 细胞分化。
Sci Rep. 2017 Sep 29;7(1):12475. doi: 10.1038/s41598-017-12750-4.

引用本文的文献

1
Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting.更短的肽核酸探针可改善基于亲合体介导的肽核酸预靶向技术。
ACS Pharmacol Transl Sci. 2024 Apr 29;7(5):1595-1611. doi: 10.1021/acsptsci.4c00106. eCollection 2024 May 10.
2
CRISPR/Cas9 Landscape: Current State and Future Perspectives.CRISPR/Cas9 全景:现状与未来展望。
Int J Mol Sci. 2023 Nov 8;24(22):16077. doi: 10.3390/ijms242216077.
3
Programmable site-specific DNA double-strand breaks via PNA-assisted prokaryotic Argonautes.通过 PNA 辅助的原核 Argonautes 实现可编程的位点特异性 DNA 双链断裂。
Nucleic Acids Res. 2023 Sep 22;51(17):9491-9506. doi: 10.1093/nar/gkad655.
4
Recent Advances in Improving Gene-Editing Specificity through CRISPR-Cas9 Nuclease Engineering.通过 CRISPR-Cas9 核酸酶工程提高基因编辑特异性的最新进展。
Cells. 2022 Jul 13;11(14):2186. doi: 10.3390/cells11142186.
5
Perspectives on conformationally constrained peptide nucleic acid (PNA): insights into the structural design, properties and applications.构象受限肽核酸(PNA)的展望:对结构设计、性质及应用的见解
RSC Chem Biol. 2022 Mar 18;3(6):648-697. doi: 10.1039/d2cb00017b. eCollection 2022 Jun 8.

本文引用的文献

1
First CRISPR therapy dosed.首例CRISPR疗法给药。
Nat Biotechnol. 2020 Apr;38(4):382. doi: 10.1038/s41587-020-0493-4.
2
Gene editing and CRISPR in the clinic: current and future perspectives.基因编辑和 CRISPR 在临床中的应用:现状与未来展望。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20200127.
3
Poly(Lactic-co-Glycolic Acid) Nanoparticle Delivery of Peptide Nucleic Acids In Vivo.体内肽核酸的聚(乳酸-共-乙醇酸)纳米粒子传递。
Methods Mol Biol. 2020;2105:261-281. doi: 10.1007/978-1-0716-0243-0_17.
4
First gene therapy for β-thalassemia approved.首个用于β地中海贫血的基因疗法获批。
Nat Biotechnol. 2019 Oct;37(10):1102-1103. doi: 10.1038/d41587-019-00026-3.
5
Development of hRad51-Cas9 nickase fusions that mediate HDR without double-stranded breaks.开发介导 HDR 而不产生双链断裂的 hRad51-Cas9 尼克酶融合蛋白。
Nat Commun. 2019 May 17;10(1):2212. doi: 10.1038/s41467-019-09983-4.
6
In utero nanoparticle delivery for site-specific genome editing.子宫内纳米颗粒传递用于特定部位的基因组编辑。
Nat Commun. 2018 Jun 26;9(1):2481. doi: 10.1038/s41467-018-04894-2.
7
Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing.肽核酸作为一种用于定点基因编辑的工具。
Molecules. 2018 Mar 11;23(3):632. doi: 10.3390/molecules23030632.
8
Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.治疗性肽核酸:原理、局限性与机遇
Yale J Biol Med. 2017 Dec 19;90(4):583-598. eCollection 2017 Dec.
9
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1.临床前模型突出了造血干细胞基因编辑治疗 X 连锁重症联合免疫缺陷病 1 型的潜力。
Sci Transl Med. 2017 Oct 11;9(411). doi: 10.1126/scitranslmed.aan0820.
10
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery.经纳米颗粒递送的 γPNA 介导的基因编辑实现β-地中海贫血小鼠体内贫血纠正。
Nat Commun. 2016 Oct 26;7:13304. doi: 10.1038/ncomms13304.

肽核酸依赖性假像可能导致假阳性三链体基因编辑信号。

Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals.

机构信息

Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305.

Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305.

出版信息

Proc Natl Acad Sci U S A. 2021 Nov 9;118(45). doi: 10.1073/pnas.2109175118.

DOI:10.1073/pnas.2109175118
PMID:34732575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8609320/
Abstract

Triplex gene editing relies on binding a stable peptide nucleic acid (PNA) sequence to a chromosomal target, which alters the helical structure of DNA to stimulate site-specific recombination with a single-strand DNA (ssDNA) donor template and elicits gene correction. Here, we assessed whether the codelivery of PNA and donor template encapsulated in Poly Lactic-co-Glycolic Acid (PLGA)-based nanoparticles can correct sickle cell disease and x-linked severe combined immunodeficiency. However, through this process we have identified a false-positive PCR artifact due to the intrinsic capability of PNAs to aggregate with ssDNA donor templates. Here, we show that the combination of PNA and donor templates but not either agent alone results in different degrees of aggregation that result in varying but highly reproducible levels of false-positive signal. We have identified this phenomenon in vitro and confirmed that the PNA sequences producing the highest supposed correction in vitro are not active in vivo in both disease models, which highlights the importance of interrogating and eliminating carryover of ssDNA donor templates in assessing various gene editing technologies such as PNA-mediated gene editing.

摘要

三重基因编辑依赖于将稳定的肽核酸 (PNA) 序列与染色体靶标结合,改变 DNA 的螺旋结构,以刺激与单链 DNA (ssDNA) 供体模板的特异性重组,并引发基因校正。在这里,我们评估了将 PNA 和包裹在聚乳酸-共-羟基乙酸 (PLGA) 纳米颗粒中的供体模板共递送至是否可以纠正镰状细胞病和 X 连锁严重联合免疫缺陷。然而,通过这个过程,我们已经确定了一种由于 PNA 与 ssDNA 供体模板固有聚集能力而产生的假阳性 PCR 假象。在这里,我们表明 PNA 和供体模板的组合,但不是单独的任何一种试剂,都会导致不同程度的聚集,从而导致不同但高度可重复的假阳性信号水平。我们已经在体外鉴定了这种现象,并证实了在两种疾病模型中,体外产生最高校正的 PNA 序列在体内均不活跃,这突出了在评估各种基因编辑技术(如 PNA 介导的基因编辑)时,检测和消除 ssDNA 供体模板残留的重要性。